Logo image of AIM.CA

AIMIA INC (AIM.CA) Stock Fundamental Analysis

TSX:AIM - Toronto Stock Exchange - CA00900Q1037 - Common Stock - Currency: CAD

2.43  +0.02 (+0.83%)

Fundamental Rating

4

AIM gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 32 industry peers in the Chemicals industry. The financial health of AIM is average, but there are quite some concerns on its profitability. AIM shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year AIM has reported negative net income.
In the past year AIM has reported a negative cash flow from operations.
In multiple years AIM reported negative net income over the last 5 years.
In the past 5 years AIM reported 4 times negative operating cash flow.
AIM.CA Yearly Net Income VS EBIT VS OCF VS FCFAIM.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M 1B

1.2 Ratios

AIM has a Return On Assets (-9.58%) which is in line with its industry peers.
Looking at the Return On Equity, with a value of -17.24%, AIM is in line with its industry, outperforming 55.17% of the companies in the same industry.
Industry RankSector Rank
ROA -9.58%
ROE -17.24%
ROIC N/A
ROA(3y)8.54%
ROA(5y)43.4%
ROE(3y)4.19%
ROE(5y)52.97%
ROIC(3y)N/A
ROIC(5y)N/A
AIM.CA Yearly ROA, ROE, ROICAIM.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100 200

1.3 Margins

Looking at the Gross Margin, with a value of 27.11%, AIM belongs to the top of the industry, outperforming 82.76% of the companies in the same industry.
AIM's Gross Margin has declined in the last couple of years.
AIM does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 27.11%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-22.29%
AIM.CA Yearly Profit, Operating, Gross MarginsAIM.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5K 10K

5

2. Health

2.1 Basic Checks

AIM does not have a ROIC to compare to the WACC, probably because it is not profitable.
AIM has more shares outstanding than it did 1 year ago.
AIM has less shares outstanding than it did 5 years ago.
AIM has a worse debt/assets ratio than last year.
AIM.CA Yearly Shares OutstandingAIM.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M
AIM.CA Yearly Total Debt VS Total AssetsAIM.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B 4B 5B

2.2 Solvency

Based on the Altman-Z score of -1.80, we must say that AIM is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of AIM (-1.80) is worse than 72.41% of its industry peers.
A Debt/Equity ratio of 0.32 indicates that AIM is not too dependend on debt financing.
The Debt to Equity ratio of AIM (0.32) is better than 62.07% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF N/A
Altman-Z -1.8
ROIC/WACCN/A
WACC8.26%
AIM.CA Yearly LT Debt VS Equity VS FCFAIM.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M 400M 600M

2.3 Liquidity

AIM has a Current Ratio of 2.73. This indicates that AIM is financially healthy and has no problem in meeting its short term obligations.
AIM has a Current ratio of 2.73. This is amongst the best in the industry. AIM outperforms 82.76% of its industry peers.
AIM has a Quick Ratio of 2.06. This indicates that AIM is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of AIM (2.06) is better than 82.76% of its industry peers.
Industry RankSector Rank
Current Ratio 2.73
Quick Ratio 2.06
AIM.CA Yearly Current Assets VS Current LiabilitesAIM.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B

7

3. Growth

3.1 Past

AIM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 49.47%, which is quite impressive.
Looking at the last year, AIM shows a very strong growth in Revenue. The Revenue has grown by 133.58%.
The Revenue has been growing by 11.75% on average over the past years. This is quite good.
EPS 1Y (TTM)49.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.08%
Revenue 1Y (TTM)133.58%
Revenue growth 3Y340.8%
Revenue growth 5Y11.75%
Sales Q2Q%12.95%

3.2 Future

AIM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.37% yearly.
Based on estimates for the next years, AIM will show a very strong growth in Revenue. The Revenue will grow by 249.94% on average per year.
EPS Next Y88.78%
EPS Next 2Y40.94%
EPS Next 3Y26.37%
EPS Next 5YN/A
Revenue Next Year3579.55%
Revenue Next 2Y534.93%
Revenue Next 3Y249.94%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AIM.CA Yearly Revenue VS EstimatesAIM.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 500M 1B 1.5B 2B
AIM.CA Yearly EPS VS EstimatesAIM.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 1 -1 -2

1

4. Valuation

4.1 Price/Earnings Ratio

AIM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AIM. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AIM.CA Price Earnings VS Forward Price EarningsAIM.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 -60 -80

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AIM indicates a somewhat cheap valuation: AIM is cheaper than 75.86% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 19.47
AIM.CA Per share dataAIM.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

A more expensive valuation may be justified as AIM's earnings are expected to grow with 26.37% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.94%
EPS Next 3Y26.37%

0

5. Dividend

5.1 Amount

No dividends for AIM!.
Industry RankSector Rank
Dividend Yield N/A

AIMIA INC

TSX:AIM (2/21/2025, 7:00:00 PM)

2.43

+0.02 (+0.83%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-08 2024-11-08/bmo
Earnings (Next)03-24 2025-03-24/amc
Inst Owners31.87%
Inst Owner ChangeN/A
Ins Owners1.25%
Ins Owner ChangeN/A
Market Cap231.85M
Analysts83.33
Price Target4.21 (73.25%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.14
Dividend Growth(5Y)N/A
DP-14.99%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)29.55%
Min EPS beat(2)-15.51%
Max EPS beat(2)74.61%
EPS beat(4)2
Avg EPS beat(4)-110.07%
Min EPS beat(4)-583.17%
Max EPS beat(4)83.8%
EPS beat(8)2
Avg EPS beat(8)-670.6%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)21.88%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.71%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.49
P/FCF N/A
P/OCF N/A
P/B 0.43
P/tB 1.64
EV/EBITDA 19.47
EPS(TTM)-0.95
EYN/A
EPS(NY)-0.03
Fwd EYN/A
FCF(TTM)-0.35
FCFYN/A
OCF(TTM)-0.21
OCFYN/A
SpS4.96
BVpS5.68
TBVpS1.48
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.58%
ROE -17.24%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 27.11%
FCFM N/A
ROA(3y)8.54%
ROA(5y)43.4%
ROE(3y)4.19%
ROE(5y)52.97%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-22.29%
F-Score5
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF N/A
Debt/EBITDA 10.67
Cap/Depr 38.89%
Cap/Sales 2.96%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.73
Quick Ratio 2.06
Altman-Z -1.8
F-Score5
WACC8.26%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)49.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.08%
EPS Next Y88.78%
EPS Next 2Y40.94%
EPS Next 3Y26.37%
EPS Next 5YN/A
Revenue 1Y (TTM)133.58%
Revenue growth 3Y340.8%
Revenue growth 5Y11.75%
Sales Q2Q%12.95%
Revenue Next Year3579.55%
Revenue Next 2Y534.93%
Revenue Next 3Y249.94%
Revenue Next 5YN/A
EBIT growth 1Y-5.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year124.87%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-168.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-57.14%
OCF growth 3YN/A
OCF growth 5YN/A